Two of the most well-known GLP-1 agonists are Wegovy and Ozempic
Those human efforts have been preliminary and mixed rather than definitively positive, which is the recurring pattern across the whole peptide-repair field: a clean, mechanistically satisfying animal result that becomes murky and inconsistent when tested in people
These physiological stressors interact bidirectionally with mental health symptoms, creating a vicious cycle in which poor metabolic health undermines psychological resilience and vice versa
SYNERGY-NASH: Tirzepatide and metabolic steatohepatitis (MASH) SYNERGY-NASH (Loomba et al., NEJM 2024, NEJMoa2401943, PMID 38856224) is a phase 2 trial in 190 patients with metabolic steatohepatitis (MASH) and biopsy-proven stage 2 or 3 fibrosis
This often exceeds results from metformin or dietary changes alone
It is very similar to a natural hormone in the body called GLP-1